Catalent, through operating subsidiary Catalent Pharma Solutions, provides contract development and manufacturing of oral (soft and hardshell capsules), topical (ointment applicators), sterile (syringes), and inhaled (nasal sprays) drug delivery products to pharmaceutical and biotechnology companies in some 100 countries. Catalent also provides packaging services, using bottles, pouches, and strips used to hold tablet, powder, and liquid medicines. Catalent operates 30 facilities worldwide. The company is controlled by The Blackstone Group.